Ojas, Hilda G.

HRN: 10-82-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2022
CEFTRIAXONE 1G (VIAL)
11/06/2022
11/12/2022
IVT
2gms
Od
Cap Mr, T/c Copd In Ae
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: